1. Home
  2. TVTX vs TIGR Comparison

TVTX vs TIGR Comparison

Compare TVTX & TIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • TIGR
  • Stock Information
  • Founded
  • TVTX 2008
  • TIGR 2014
  • Country
  • TVTX United States
  • TIGR China
  • Employees
  • TVTX N/A
  • TIGR N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • TIGR Investment Bankers/Brokers/Service
  • Sector
  • TVTX Health Care
  • TIGR Finance
  • Exchange
  • TVTX Nasdaq
  • TIGR Nasdaq
  • Market Cap
  • TVTX 1.8B
  • TIGR 1.6B
  • IPO Year
  • TVTX N/A
  • TIGR 2019
  • Fundamental
  • Price
  • TVTX $21.98
  • TIGR $8.20
  • Analyst Decision
  • TVTX Strong Buy
  • TIGR Hold
  • Analyst Count
  • TVTX 12
  • TIGR 2
  • Target Price
  • TVTX $30.08
  • TIGR $6.54
  • AVG Volume (30 Days)
  • TVTX 1.8M
  • TIGR 8.3M
  • Earning Date
  • TVTX 02-20-2025
  • TIGR 03-19-2025
  • Dividend Yield
  • TVTX N/A
  • TIGR N/A
  • EPS Growth
  • TVTX N/A
  • TIGR N/A
  • EPS
  • TVTX N/A
  • TIGR 0.19
  • Revenue
  • TVTX $233,175,000.00
  • TIGR $277,352,627.00
  • Revenue This Year
  • TVTX $62.88
  • TIGR $70.34
  • Revenue Next Year
  • TVTX $57.60
  • TIGR $19.56
  • P/E Ratio
  • TVTX N/A
  • TIGR $43.08
  • Revenue Growth
  • TVTX 60.55
  • TIGR 21.52
  • 52 Week Low
  • TVTX $5.12
  • TIGR $3.10
  • 52 Week High
  • TVTX $25.29
  • TIGR $14.48
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 53.52
  • TIGR 58.27
  • Support Level
  • TVTX $22.48
  • TIGR $8.06
  • Resistance Level
  • TVTX $23.69
  • TIGR $9.29
  • Average True Range (ATR)
  • TVTX 1.22
  • TIGR 0.63
  • MACD
  • TVTX -0.02
  • TIGR 0.06
  • Stochastic Oscillator
  • TVTX 41.10
  • TIGR 58.07

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

About TIGR UP Fintech Holding Ltd representing fifteen

UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.

Share on Social Networks: